Company profile: ActivaTek
1.1 - Company Overview
Company description
- Provider of drug delivery and other medical devices, including iontophoretic products for the rehabilitation market. Manufacturer of ActivaDose dose controllers; ActivaDose II houses a 9-volt battery and features precise dosing, visual and audible displays, and dual channels.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ActivaTek
Optinose
HQ: Norway
Website
- Description: Provider of nasal drug delivery technologies and combination drug/device therapies based on Bi-Directional Delivery, including Exhalation Delivery Systems for efficient deep nasal delivery. Offerings include XHANCE nasal spray for nasal polyps, ONZETRA Xsail for migraine treatment, and liquid and powder delivery devices using exhaled breath.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Optinose company profile →
Clene
HQ: United States
Website
- Description: Provider of nanomedicine therapeutics for neurodegenerative diseases (ALS, MS, Parkinson's Disease), infectious diseases, and oncology applications: CNM-Au8 oral gold nanocrystals; CNM-ZnAg zinc-silver ionic solution with antiviral/antimicrobial properties; CNM-AgZn17 topical silver/zinc gel for infections and wound healing; CNM-PtAu7 gold-platinum nanotherapeutic with efficacy across tumor cell lines in initial research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clene company profile →
Xeris Biopharma
HQ: United States
Website
- Description: Provider of pharmaceutical therapies in endocrinology, neurology, and gastroenterology, including Gvoke and Ogluo ready-to-use glucagon injections for severe hypoglycemia; Keveyis, the first FDA-approved treatment for Primary Periodic Paralysis; Recorlev for endogenous Cushing's syndrome; and levothyroxine for hypothyroidism. Ogluo is marketed in the UK/EU under an exclusive agreement with Tetris Pharma.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xeris Biopharma company profile →
Biocorp Systems
HQ: France
Website
- Description: Provider of medical devices and drug delivery systems; a pharmaceutical company that develops, manufactures, and markets these products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biocorp Systems company profile →
TriSalus
HQ: United States
Website
- Description: Provider of novel infusion systems for the interventional radiology market, including Pressure-Enabled Drug Delivery to overcome intratumoral pressure and enhance local drug concentrations; an integrated platform combining immunomodulation therapy with proprietary intravascular regional delivery for liver and pancreatic tumors; and investigational TLR9 agonist nelitolimod (SD-101), evaluated in ongoing PERIO-01 and PERIO-02 clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriSalus company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ActivaTek
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ActivaTek
2.2 - Growth funds investing in similar companies to ActivaTek
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ActivaTek
4.2 - Public trading comparable groups for ActivaTek
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →